title: Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?
authors.forename: Kathleen E
authors.initials: KE
authors.lastname: Corey
authors.forename: Naga
authors.initials: N
authors.lastname: Chalasani
mesh_terms: D005234:Fatty Liver / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D019808:Losartan / Q000008:administration & dosage*; D008297:Male; D008687:Metformin / Q000008:administration & dosage*; D065626:Non-alcoholic Fatty Liver Disease; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000008:administration & dosage*
chemical_list: D045162:Thiazolidinediones; D000077154:Rosiglitazone; D008687:Metformin; D019808:Losartan